Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Weed Week: An Aussie medicinal cannabis farm for sale and crypto ATMs in weed dispensaries
15 Jul 2022
Published by: Stockhead
Weed Week: Cannabis lounges in Las Vegas and Cann’s Mildura cannabis facility gets GMP licence
01 Jul 2022
Published by: Stockhead
Bod’s S3 registration candidate to go on sale through Special Access Scheme
27 Jun 2022
Published by: Cannabiz
Bod Australia (ASX:BOD) to launch new medicinal cannabis product in July
23 Jun 2022
Published by: The Market Herald
Could Aussie cannabinoid companies help solve a global opioid crisis?
07 Jun 2022
Published by: Stockhead
Weed Week: Sydney Uni says it’s okay to CBD ‘n drive, and cannabis-infused drinks on the rise
06 Jun 2022
Published by: Stockhead
Bod Reports Positive Results From Medical Cannabis Study
27 May 2022
Published by: Hemp Gazette